Clemens Lakner, PhD, MBA, joined the previous biopharma fund in 2015 as an Analyst and was hired as Associate in the Life Science team in April 2016. Prior to that he was an MBA intern at BASF Venture Capital and staff at the European Molecular Biology Laboratory in Heidelberg. Clemens received his MSc in biological science from Vienna University and his PhD from Florida State University. During his studies he spent 12 months at Uppsala University and six months at the European Bioinformatics Institute in the UK. He continued his scientific work as a postdoc at North Carolina State University, where he focused on protein structure in the context of statistical models of evolution. He recently completed his MBA at Aston Business School in Birmingham, UK. For his MBA project he explored a financial simulation model and benchmarked venture capital deals across different industries. Clemens is based in Darmstadt.